Search results for "228"

showing 10 items of 834 documents

Insomnia symptoms combined with nocturnal hypoxia associate with cardiovascular comorbidity in the European sleep apnea cohort (ESADA)

2018

WOS: 000482433800011

AdultMalemedicine.medical_specialtyInsomniaNeurologyComorbiditySettore MED/10 - Malattie Dell'Apparato RespiratorioNocturnalHypoxemiaHypoxemia03 medical and health sciences0302 clinical medicineRisk FactorsSleep Initiation and Maintenance DisordersInternal medicinemental disordersPrevalenceInsomniaHumansMedicineHypoxiaSleep Apnea Obstructivebusiness.industrySleep Breathing Physiology and Disorders • Original ArticleSleep apneaSleep apneaMiddle AgedCardiovascular disease ; Comorbidity ; Hypoxemia ; Insomnia ; Phenotype ; Sleep apnea.Hypoxia (medical)Cardiovascular diseasemedicine.diseaseComorbidityCircadian Rhythmnervous system diseasesEuropePhenotype030228 respiratory systemOtorhinolaryngologyCardiovascular DiseasesCohortFemaleHuman medicineNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgerySleep and Breathing
researchProduct

Sex difference and intra-operative tidal volume: Insights from the LAS VEGAS study

2021

BACKGROUND: One key element of lung-protective ventilation is the use of a low tidal volume (V(T)). A sex difference in use of low tidal volume ventilation (LTVV) has been described in critically ill ICU patients. OBJECTIVES: The aim of this study was to determine whether a sex difference in use of LTVV also exists in operating room patients, and if present what factors drive this difference. DESIGN, PATIENTS AND SETTING: This is a posthoc analysis of LAS VEGAS, a 1-week worldwide observational study in adults requiring intra-operative ventilation during general anaesthesia for surgery in 146 hospitals in 29 countries. MAIN OUTCOME MEASURES: Women and men were compared with respect to use o…

AdultMalemedicine.medical_specialtyIntra operativehealth care facilities manpower and services[SDV]Life Sciences [q-bio]Critical IllnessLas Vegas StudyArticle03 medical and health sciences0302 clinical medicine030202 anesthesiologyInternal medicineTidal VolumemedicineHumansGeneral anaesthesiaLungTidal volumeAdult; Critical Illness; Female; Humans; Lung; Male; Tidal Volume; Respiration Artificial; Sex CharacteristicsSex CharacteristicsLas vegasbusiness.industryRespirationrespiratory failure sexrespiratory systemSex differenceRespiration Artificialrespiratory tract diseasesAnesthesiology and Pain Medicine030228 respiratory systemRelative riskArtificialCohortBreathingFemaleObservational studybusinessintra-operative tidal volumecirculatory and respiratory physiology
researchProduct

Effects of Particulate Matter on the Incidence of Respiratory Diseases in the Pisan Longitudinal Study

2020

The current study aimed at assessing the effects of exposure to Particulate Matter (PM) on the incidence of respiratory diseases in a sub-sample of participants in the longitudinal analytical epidemiological study in Pisa, Italy. Three hundred and five subjects living at the same address from 1991 to 2011 were included. Individual risk factors recorded during the 1991 survey were considered, and new cases of respiratory diseases were ascertained until 2011. Average PM10 and PM2.5 exposures (&micro

AdultMalemedicine.medical_specialtyLongitudinal studyPercentilelong-term exposureair pollution;Health Toxicology and Mutagenesisair pollutionRespiratory Tract Diseaseslcsh:Medicinerandom forest;010501 environmental sciencesLogistic regression01 natural sciencesArticle03 medical and health sciences0302 clinical medicinequestionnaire;Environmental healthEpidemiologyMedicineHumansLongitudinal StudiesRespiratory systemRespiratory healthrespiratory symptoms/diseases0105 earth and related environmental sciencesAgedparticulate matterAir Pollutantsbusiness.industryIncidence (epidemiology)questionnaireIncidencelcsh:RPublic Health Environmental and Occupational HealthEnvironmental ExposureParticulatesMiddle Aged030228 respiratory systemItalyFemalebusinessrandom forestparticulate matter;International Journal of Environmental Research and Public Health
researchProduct

Vitamin D deficiency in patients evaluated for obstructive sleep apnea: is it associated with disease severity?

2019

Purpose: The aim of the present study was to assess vitamin D levels in a large cohort of OSA patients and to investigate possible correlations with clinical and polysomnographic parameters. Methods: In this cross-sectional study, 685 consecutive patients underwent type 1 polysomnography (PSG) for OSA diagnosis. They were grouped according to apnea–hypopnea index (AHI) as mild, moderate, and severe. Patients with AHI < 5 served as controls. Demographic, PSG data, and serum levels of vitamin D were measured and compared between groups. Results: OSA was diagnosed in 617 of the patients (90%). Of those, 94 (15%) had mild OSA, 150 (24%) moderate OSA, and 373 (61%) severe OSA. The risk of vit…

AdultMalemedicine.medical_specialtyNeurologyVitamin D deficiency.PolysomnographyPolysomnographySettore MED/10 - Malattie Dell'Apparato RespiratorioGastroenterologyvitamin D deficiencyCohort Studies03 medical and health sciences0302 clinical medicinestomatognathic systemInternal medicinemedicineVitamin D and neurologyHumansVitamin DSleep Apnea Obstructivemedicine.diagnostic_testbusiness.industryPatient AcuityMiddle Agedmedicine.diseaseVitamin D DeficiencyObesityObstructive sleep apneanervous system diseasesrespiratory tract diseasesObstructive sleep apneaCross-Sectional Studies030228 respiratory systemOtorhinolaryngologyOtorhinolaryngologyCohortFemaleNeurology (clinical)business030217 neurology & neurosurgerySleepbreathing = SchlafAtmung
researchProduct

Development and validation of the mastocytosis quality of life questionnaire: MC-QoL

2016

Background Mastocytosis is a heterogeneous disease characterized by a clonal expansion of mast cells in various organs. The vast majority of patients affected suffer from signs and symptoms caused by mediator release from mast cells. Although the disease burden is high, there is currently no specific instrument to measure health-related quality of life (HRQoL) impairment in patients with mastocytosis. Objective The aim of this study was to develop and validate a disease-specific tool to assess HRQoL impairment in patients with cutaneous and indolent systemic mastocytosis, the Mastocytosis Quality of Life Questionnaire (MC-QoL). Methods Sixty-two potential MC-QoL items were developed in a co…

AdultMalemedicine.medical_specialtyPathologyAdolescentImmunologyDiseaseMediator releaseYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineQuality of lifeSurveys and QuestionnairesInternal medicinemedicineHumansImmunology and AllergyIn patientSystemic mastocytosisDisease burdenAgedFace validityAged 80 and overbusiness.industryReproducibility of ResultsMiddle Agedmedicine.diseasehumanitiesCombined approach030228 respiratory systemPopulation SurveillanceQuality of LifeFemaleFactor Analysis StatisticalbusinessMastocytosisAllergy
researchProduct

Controversies and challenges in the management of chronic urticaria

2016

This supplement reports proceedings of the second international Global Urticaria Forum, which was held in Berlin, Germany in November 2015. Despite the clear international guideline, there remain a number of controversies and challenges in the management of patients with chronic urticaria (CU). As a result of major advancements in urticaria over the past 4 years, the current EAACI/GA(2) LEN/EDF/WAO urticaria guideline treatment algorithm requires updating. Case studies from patients with chronic spontaneous urticaria (CSU) [also called chronic idiopathic urticaria (CIU)], chronic inducible urticaria (CIndU) or diseases and syndromes related to CU are useful in describing and exploring chall…

AdultMalemedicine.medical_specialtyPathologyUrticariaAlternative medicineDermatologyUnmet needs030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineimmune system diseasesparasitic diseasesmedicineHumansAngioedemaDisease management (health)ChildIntensive care medicineskin and connective tissue diseasesChronic urticariaAgedbusiness.industryGuidelineMiddle AgedPedigreeCold TemperatureInfectious Diseases030228 respiratory systemChronic DiseaseHistamine H1 AntagonistsSunlightFemaleChronic idiopathic urticariabusiness
researchProduct

Effects of cumulative sleep restriction on self-perceptions while multitasking

2012

Summary This study addressed a rarely studied question of self-perceptions of performance and overall functional state during cumulative sleep restriction and the ensuing recovery period. Twenty healthy male volunteers, aged 19–29 years, were divided into a sleep restriction group (n = 13) and a control group (n = 7). On the first 2 nights, the sleep restriction group had an 8-h sleep opportunity that was restricted to 4 h for the next 5 nights, and then restored to 8 h for the last 2 nights. The control group had an 8-h sleep opportunity each night. Each day participants accomplished 50-min multitask sessions and gave self-ratings in their connection. Similar to our previous findings on mu…

AdultMalemedicine.medical_specialtyPolysomnographyCognitive Neurosciencemedia_common.quotation_subjectMental fatigueSleep inertiaDisorders of Excessive SomnolenceNeuropsychological TestsAudiologyTask (project management)Developmental psychologyYoung Adult03 medical and health sciencesBehavioral Neuroscience0302 clinical medicineSleep debtPerceptionTask Performance and AnalysismedicineHumansHuman multitaskingta515Fatiguemedia_commonSleep restrictionta3141ta3142General MedicineSelf Concept030228 respiratory systemSleep DeprivationSleep (system call)SleepPsychologyPsychomotor Performance030217 neurology & neurosurgeryJournal of Sleep Research
researchProduct

The Apnea-Hypopnea Index Underestimates Systemic Inflammation in Women with Sleep-Disordered Breathing.

2018

Evidence suggests that sleep-related respiratory and related metabolic compromise may vary between females and males with sleep-disordered breathing (SDB). Our purpose was to elucidate possible gender differences in sleep-associated respiratory and inflammatory parameters in patients with SDB.A consecutive number of SDB patients (46 females and 167 males) who underwent polysomnography were retrospectively reviewed. Fibrinogen and C-reactive protein (CRP) concentration, apnea index (ApnI), hypopnea index (HypI), apnea-hypopnea index (AHI), average and minimal SpOApnI and AHI were significantly higher in males. Correlation analysis revealed striking gender differences: only in females, CRP co…

AdultMalemedicine.medical_specialtyPolysomnographyPolysomnography030204 cardiovascular system & hematologyBody Mass Index03 medical and health sciences0302 clinical medicineSleep Apnea SyndromesRisk FactorsInternal medicinemedicineHumansObesityAgedRetrospective StudiesInflammationSleep Apnea Obstructivebiologymedicine.diagnostic_testbusiness.industryC-reactive proteinSnoringApneaFibrinogenGeneral MedicineMiddle Agedmedicine.diseasenervous system diseasesrespiratory tract diseasesObstructive sleep apneaC-Reactive Protein030228 respiratory systemApnea–hypopnea indexCardiologyBreathingbiology.proteinFemalemedicine.symptombusinessHypopneaBody mass indexJournal of women's health (2002)
researchProduct

The potential role of 13-valent pneumococcal conjugate vaccine in preventing respiratory complications in bacteraemic pneumococcal community-acquired…

2015

Abstract Introduction Pneumococcal 13-valent vaccine (PCV-13) has a potential role in preventing bacteraemic pneumococcal pneumonia and its complications, but little is known about its ability to specifically prevent respiratory complications. Our aim were to analyse the pneumococcal serotypes associated with the development of respiratory complications and the potential role of PCV-13 in preventing respiratory complications in bacteraemic pneumococcal pneumonia. Material and methods We analysed demographic characteristics, comorbidities, antibiotic resistances and the outcomes of a cohort of 65 vaccine-naive bacteraemic pneumococcal pneumonias, stratified by the pneumococcal serotypes incl…

AdultMalemedicine.medical_specialtyPopulationBacteremiamedicine.disease_causeSerogroupPneumococcal conjugate vaccineHypoxemiaPneumococcal Vaccines03 medical and health sciences0302 clinical medicineCommunity-acquired pneumoniaInternal medicineStreptococcus pneumoniaemedicineHumans030212 general & internal medicineIntensive care medicineeducationAgedRetrospective StudiesAged 80 and overCOPDeducation.field_of_studyVaccines ConjugateGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryPublic Health Environmental and Occupational HealthMiddle AgedPneumonia Pneumococcalmedicine.diseaseCommunity-Acquired InfectionsPneumoniaInfectious DiseasesStreptococcus pneumoniae030228 respiratory systemPneumococcal pneumoniaMolecular MedicineFemalemedicine.symptombusinessmedicine.drugVaccine
researchProduct

Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial.

2018

Current treatments for long-term prophylaxis in hereditary angioedema have limitations.To assess the efficacy of lanadelumab, a fully human monoclonal antibody that selectively inhibits active plasma kallikrein, in preventing hereditary angioedema attacks.Phase 3, randomized, double-blind, parallel-group, placebo-controlled trial conducted at 41 sites in Canada, Europe, Jordan, and the United States. Patients were randomized between March 3, 2016, and September 9, 2016; last day of follow-up was April 13, 2017. Randomization was 2:1 lanadelumab to placebo; patients assigned to lanadelumab were further randomized 1:1:1 to 1 of the 3 dose regimens. Patients 12 years or older with hereditary a…

AdultMalemedicine.medical_specialtyRandomizationAdolescentInjections SubcutaneousLanadelumabPlaceboAntibodies Monoclonal Humanizedlaw.invention03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineHumans030212 general & internal medicineYoung adultAdverse effectChildPlasma KallikreinAgedHereditary Angioedema Types I and IIbusiness.industryAntibodies MonoclonalCorrectionGeneral MedicineMiddle Agedmedicine.diseaseClinical trial030228 respiratory systemHereditary angioedemaQuality of LifeFemalebusinessJAMA
researchProduct